Olink

Olink®
Part of Thermo Fisher Scientific

Filters

PublicationDisease areaApplication areaSample typeProducts

Cardiovascular Research, 2025
Plasma proteomic and metabolomic profiling of coronary and carotid atherosclerosis in the SCAPIS study—differences and similarities

Fall T., Gummesson A., Hammar U. et al.

Olink Target 96CVDPatient StratificationPlasma

International Journal of Molecular Sciences, 2025
Unraveling the COVID-19 Severity Hubs and Interplays in Inflammatory-Related RNA–Protein Networks

Park H., Wang Q., Hasegawa T. et al.

Olink Explore 3072/384Infectious DiseasesPathophysiologyBlood

The Journal of Dermatology, 2025
Immunoproteomic Response to IL17A Blockade in a Patient With Generalized Pustular Psoriasis: New Insights From Plasma Olink Profiling

Jeng Y., Liao Y., Hong Y. et al.

Olink Target 96Dermatological DiseasesPathophysiologyPlasma

Journal of Cardiology, 2025
Causal relationship between circulating inflammatory proteins and atherosclerosis: a bidirectional Mendelian randomization study and meta-analysis

Xu B., Xu Q., Wang Y. et al.

Olink Target 96CVDPathophysiologyPlasma

Molecular Neurobiology, 2025
Uncovering Potential Susceptibility Genes for Multiple Sclerosis-Induced Neuropathic Bladder: A Mendelian Randomization Analysis

Xu Y., Xiong J., Wu Y. et al.

Olink Explore 3072/384NeurologyUrologyPathophysiologyPlasma

The Journal of Nutrition, 2025
Metabolomic and Proteomic Signatures of Ultra-processed Foods Are Positively Associated with Adverse Liver Outcomes

Zhao L., Chen Y., Clay-Gilmour A. et al.

Olink Explore 3072/384Metabolic DiseasesNutritional SciencePathophysiologyPlasma

Journal of the American College of Cardiology, 2025
Effect of Empagliflozin on the Mechanisms Driving Erythropoiesis and Iron Mobilization in Patients With Heart Failure

Ferreira J., Anker S., Butler J. et al.

Olink Explore 3072/384CVDPathophysiologyPlasma

BMC Pregnancy and Childbirth, 2025
Sleeping for two: a cross-sectional study on associations between objectively measured sleep during early to mid-pregnancy and maternal and fetal outcomes and inflammatory biomarker profiles

Macdonald C., Pitsillos T., Wikström A. et al.

Olink Target 96ObstetricsPathophysiologyPlasma

International Immunopharmacology, 2025
The interplay between systemic inflammation and myopia: A bidirectional Mendelian randomization and experimental validation study

Huang Z., Zhou J., Liu S. et al.

Olink Target 96Olink Explore 3072/384OphthalmologyPathophysiologyPlasma

Journal of Advanced Research, 2025
Plasma proteomics identify novel biomarkers and dynamic patterns of biological aging

Ma L., Liu W., He Y. et al.

Olink Explore 3072/384AgingPathophysiologyPlasma

Discover Oncology, 2025
Integrating analysis of multi-omics summary data identifies novel plasma protein biomarkers and drug targets for bladder cancer

Cao J., Chen S., Wang J. et al.

Olink Explore 3072/384OncologyPathophysiologyPlasma

Nature Immunology, 2025
Identification of soluble biomarkers that associate with distinct manifestations of long COVID

Gao Y., Cai C., Adamo S. et al.

Olink Explore 3072/384Infectious DiseasesPatient StratificationPlasma

Scientific Reports, 2025
Profiling 92 circulating neurobiological proteins identifies novel candidate biomarkers of long-term cognitive outcome after ischemic stroke

Lagging C., Pedersen A., Petzold M. et al.

Olink Target 96NeurologyPatient StratificationPlasma

Investigational New Drugs, 2025
Safety, tolerability, and preliminary efficacy of nadunolimab, an anti-IL- 1 receptor accessory protein monoclonal antibody, in combination with pembrolizumab in patients with solid tumors

Cohen R., Jimeno A., Hreno J. et al.

Olink Target 96OncologyImmunotherapyPathophysiology

Journal of Neurochemistry, 2025
IgD‐CD38‐B Cell Partially Mediates the Protective Effect of Higher Serum Triacylglycerol (53:4) Levels Against Parkinson's Disease

Jing Y., Zhu H., Yao P. et al.

Olink Target 96NeurologyPathophysiologyPlasma

Stroke, 2025
Proteome-Wide Genetic Study in East Asians and Europeans Identified Multiple Therapeutic Targets for Ischemic Stroke

Yao P., Mazidi M., Pozarickij A. et al.

Olink Explore 3072/384NeurologyPathophysiologyPlasma

Biomarker Research, 2025
The overlooked trio: sleep duration, sampling time and physical exercise alter levels of olink-assessed blood biomarkers of cardiovascular risk

Brandão L., Zhang L., Grip A. et al.

Olink Target 96CVDTechnical EvaluationSerum

Scientific Reports, 2025
Ophthalmological manifestations and plasma markers of inflammation in Ebola survivors in post-treatment era

Mwanza J., Kahindo A., Mbusa-Kombi J. et al.

Olink Explore 3072/384Infectious DiseasesOphthalmologyPatient StratificationPlasma

Neurobiology of Disease, 2025
Proximity extension assay reveals serum inflammatory biomarkers in two amyotrophic lateral sclerosis cohorts

Chen Y., Sun S., Gao N. et al.

Olink Target 96NeurologyPathophysiologyPatient StratificationSerum

Cancer Research, 2025
Combining Spatial Transcriptomics, Pseudotime, and Machine Learning Enables Discovery of Biomarkers for Prostate Cancer

Smelik M., Diaz-Roncero Gonzalez D., An X. et al.

Olink Explore 3072/384OncologyPatient StratificationPlasma

3899 publications